Drug Type Biosimilar, Hormone |
Synonyms Somatropin (Horizon Pharma/Ferring), JR-401A, JR-401S + [6] |
Target |
Mechanism GHR agonists(Growth hormone receptor agonists) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (25 May 1995), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02691 | Somatropin(Ferring Bv) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Growth Disorders | US | 25 May 1995 | |
Growth hormone deficiency | US | 25 May 1995 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Turner Syndrome | Phase 3 | CZ | 01 Oct 2005 | |
Turner Syndrome | Phase 3 | FR | 01 Oct 2005 | |
Turner Syndrome | Phase 3 | NL | 01 Oct 2005 |